Evidence map›Paper›PMID 31852220›Full record

ArticleArteriosclerosis, thrombosis, and vascular biology2020

Retinoids Repress Human Cardiovascular Cell Calcification With Evidence for Distinct Selective Retinoid Modulator Effects.

Maximillian A Rogers, Jiaohua Chen, Shriram Nallamshetty, Tan Pham, Shinji Goto, Jochen D Muehlschlegel, Peter Libby, Masanori Aikawa, Elena Aikawa, Jorge Plutzky

Open access · bronzeAbstract readComparative Study
In one paragraph

Article in Arteriosclerosis, thrombosis, and vascular biology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
1.3field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 29 citations in OpenAlex.

  1. Retinoic acid in health and disease.Signal transduction and targeted therapy · 2026
    Review
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Review
  8. Review
  9. Article
  10. Review
  11. Article
  12. Review
  13. Review
  14. Review
  15. Review
  16. Review
  17. Roles of Nuclear Receptors in Vascular Calcification.International journal of molecular sciences · 2021
    Review
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

10 authors at 1 institution in 1 country.

Maximillian A RogersFrom the Division of Cardiovascular Medicine, Center for Interdisciplinary Cardiovascular Sciences (M.A.R., T.P., S.G., M.A., E.A.), Brigham and Women's Hospital, Harvard Medical School, Boston, MA.
Jiaohua ChenDivision of Cardiovascular Medicine, Center for Excellence in Vascular Biology (J.C., S.N., P.L., M.A., E.A., J.P.), Brigham and Women's Hospital, Harvard Medical School, Boston, MA.
Shriram NallamshettyDivision of Cardiovascular Medicine, Center for Excellence in Vascular Biology (J.C., S.N., P.L., M.A., E.A., J.P.), Brigham and Women's Hospital, Harvard Medical School, Boston, MA.
Tan PhamFrom the Division of Cardiovascular Medicine, Center for Interdisciplinary Cardiovascular Sciences (M.A.R., T.P., S.G., M.A., E.A.), Brigham and Women's Hospital, Harvard Medical School, Boston, MA.
Shinji GotoFrom the Division of Cardiovascular Medicine, Center for Interdisciplinary Cardiovascular Sciences (M.A.R., T.P., S.G., M.A., E.A.), Brigham and Women's Hospital, Harvard Medical School, Boston, MA.
Jochen D MuehlschlegelDepartment of Anesthesiology, Perioperative and Pain Medicine (J.D.M.), Brigham and Women's Hospital, Harvard Medical School, Boston, MA.
Peter LibbyDivision of Cardiovascular Medicine, Center for Excellence in Vascular Biology (J.C., S.N., P.L., M.A., E.A., J.P.), Brigham and Women's Hospital, Harvard Medical School, Boston, MA.
Masanori AikawaFrom the Division of Cardiovascular Medicine, Center for Interdisciplinary Cardiovascular Sciences (M.A.R., T.P., S.G., M.A., E.A.), Brigham and Women's Hospital, Harvard Medical School, Boston, MA.
Elena AikawaFrom the Division of Cardiovascular Medicine, Center for Interdisciplinary Cardiovascular Sciences (M.A.R., T.P., S.G., M.A., E.A.), Brigham and Women's Hospital, Harvard Medical School, Boston, MA.
Jorge PlutzkyFrom the Division of Cardiovascular Medicine, Center for Interdisciplinary Cardiovascular Sciences (M.A.R., T.P., S.G., M.A., E.A.), Brigham and Women's Hospital, Harvard Medical School, Boston, MA.
Brigham and Women's Hospital · US

Funding

Tissue AnalysesP01HL048743 · NHLBI · BRIGHAM AND WOMEN'S HOSPITAL · PI GLADYSHEV, VADIM N. · 1992 to 2014
$26.3M
Improving Mitral Compensation In Ischemic RegurgitationR01HL141917 · NHLBI · MASSACHUSETTS GENERAL HOSPITAL · PI AIKAWA, ELENA, BISCHOFF, JOYCE E. · 2018 to 2021
$5.6M
Macrophage-derived microcalcificaitonsR01HL136431 · NHLBI · BRIGHAM AND WOMEN'S HOSPITAL · PI AIKAWA, ELENA · 2017 to 2020
$2.7M
New driver of fibrosis and calcification in CAVDR01HL147095 · NHLBI · BRIGHAM AND WOMEN'S HOSPITAL · PI AIKAWA, ELENA · 2019 to 2022
$2.4M
Aortic valve microcalcificationR01HL114805 · NHLBI · BRIGHAM AND WOMEN'S HOSPITAL · PI AIKAWA, ELENA · 2012 to 2016
$2.1M
Novel mechanisms of the thrombotic complications of atherosclerosisR01HL134892 · NHLBI · BRIGHAM AND WOMEN'S HOSPITAL · PI LIBBY, PETER · 2019 to 2022
$1.7M
NHLBI NIH HHS P01 HL048743NHLBI NIH HHS R01 HL114805NHLBI NIH HHS R01 HL134892NHLBI NIH HHS R01 HL136431NHLBI NIH HHS R01 HL141917NHLBI NIH HHS R01 HL147095
6 · The paper itself

Abstract

objectiveRetinoic acid (RA) is a ligand for nuclear receptors that modulate gene transcription and cell differentiation. Whether RA controls ectopic calcification in humans is unknown. We tested the hypothesis that RA regulates osteogenic differentiation of human arterial smooth muscle cells and aortic valvular interstitial cells that participate in atherosclerosis and heart valve disease, respectively. Approach and Results: Human cardiovascular tissue contains immunoreactive RAR (RA receptor)-a retinoid-activated nuclear receptor directing multiple transcriptional programs. RA stimulation suppressed primary human cardiovascular cell calcification while treatment with the RAR inhibitor AGN 193109 or

conclusionsThese results establish retinoid regulation of human cardiovascular calcification, provide new insight into mechanisms involved in these responses, and suggest selective retinoid modulators, like acyclic retinoids may allow for treating cardiovascular calcification without the adverse effects associated with cyclic retinoids.

Indexed as

Alkaline PhosphataseAortic ValveApolipoprotein C-IIICalcium-Binding ProteinsCarotid ArteriesCarrier ProteinsCells, CulturedCholesterol 7-alpha-HydroxylaseCoronary VesselsExtracellular Matrix ProteinsHeart Valve DiseasesHumansIsotretinoinMatrix Gla ProteinMuscle, Smooth, VascularMyocytes, Smooth Muscle(2E,4E,6E,10E)-3,7,11,15-tetramethyl-2,4,6,10,14-hexadecapentaenoic acidAlkaline PhosphataseALPL protein, humanAPOC3 protein, humanApolipoprotein C-IIICalcium-Binding ProteinsCarrier ProteinsCholesterol 7-alpha-HydroxylaseCYP7A1 protein, humanExtracellular Matrix ProteinsIsotretinoinMatrix Gla ProteinReceptors, Retinoic AcidRetinoidsTretinoincell differentiationhumansosteoblastsretinoidstretinoin

Identifiers

PMID31852220
PMCPMC7047603
OpenAlexW2994815769

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.